Status: Not yet recruiting
Study of SP-3164 in Relapsed or Refractory Non-Hodgkin's Lymphoma
The purpose of this research is to help researchers find out if SP-3164 is safe and if it may be of benefit in the treatment of patients with Non-Hodgkin's lymphoma that has progressed after prior treatment, or that never responded to previous treatment.
Participants needed: 72
Trial details
Phase: Early Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Salarius Pharmaceuticals, LLCUpdated: Nov 22, 2023
Eligibility criteria
require treatment in the opinion of the Investigator [+1]